Life Sciences & Health Technology

Cultivation Capital’s healthcare and life sciences team has invested in early-stage life sciences companies, primarily in the therapeutics, diagnostics, research tools and reagents, medical devices, and healthcare information technology verticals. We are actively investing in digital health technologies in remote care, hospital efficiency, supply chain, clinical research and other long term gaps that were identified as a result of the COVID-19 pandemic. Our sweet spot is providing post-seed/pre-Series A stage companies the capital they need to rapidly scale their businesses. Our initial investment ranges from $250,000 – $1,000,000, with opportunities for follow-on investment.

Our partners are seasoned entrepreneurs and investors who know what it takes to grow and successfully exit a business. Drawing upon their expertise, we actively support our portfolio companies, often serving as a lead investor and board member.

Agathos
Aptimmune
Arch Oncology
Cardialen
Euclises
Euphrates Vascular
Fifth Eye
ImageMover
Immunophotonics
Medici
MOBILion Systems, Inc.
Mobius Therapeutics
Orbita
Redox
SentiAR
Sequoia Sciences
Menu